Navigation Links
Bextra Whistleblower Case Started Investigation of Pfizer
Date:9/2/2009

WASHINGTON, Sept. 2 /PRNewswire/ -- The decision by a Pfizer sales representative in Florida to file a whistleblower ("qui tam") lawsuit in 2003 kicked off the federal and state investigations that led to Pfizer's record-breaking $2.3 billion settlement today.

"In the Army, I was expected to protect people at all costs," said the whistleblower, John Kopchinski, a West Point graduate and Gulf War veteran. "At Pfizer I was expected to increase profits at all costs, even when sales meant endangering lives. I couldn't do that."

The largest piece of the settlement -- $1.8 billion -- is solely due to Pfizer's improper "off-labeling" marketing of Bextra that Kopchinski exposed through his qui tam lawsuit. Pfizer is paying $502 million to settle civil charges and an historic $1.3 billion criminal fine both relating to Bextra marketing.

The FDA approved Bextra to treat arthritis as well as menstrual pain in very limited doses. Kopchinski alleged in his qui tam lawsuit -- which the government joined -- that Pfizer promoted Bextra for uses and in doses that far exceeded what the FDA had approved. This put patients at risk for serious health problems such as heart attack, stroke and pulmonary embolism (blood clot in the lung). The lawsuit also said that Bextra paid doctors kickbacks in various ways to influence them to prescribe and endorse Bextra for these "off-label" uses. Bextra was withdrawn from the market in 2005.

"Even though the FDA rejected Pfizer's application to sell Bextra for certain uses because of serious health risks, Pfizer had the gall to push those uses anyway using misleading information," said Erika A. Kelton, a Washington, D.C. lawyer whose firm, Phillips & Cohen LLP, represents the whistleblower. "Ignoring serious health risks to increase sales is outrageous."

(For details about the allegations involving Bextra, see Kopchinski's qui tam complaint on the Phillips & Cohen website at www.phillipsandcohen.com.)

As provided by the False Claims Act, the federal government will award Kopchinski $51.5 million as a reward for the work he and his attorneys did on the case. He also will receive an undetermined reward under state false claims laws.

Ironically, Kopchinski was personally hired as a sales representative in 1992 by Edward Pratt, the chairman and chief executive officer of Pfizer at that time, after Kopchinski began corresponding with Pratt while serving as an Army officer in the Gulf War. Kopchinski worked for Pfizer for 11 years.

"It was wrong what Pfizer told its sales representatives to do," Kopchinski said. "Fortunately, once the government found out what was going on, it acted quickly to protect patients."

Attorney Kelton praised the work of the U.S. Department of Justice -- particularly Assistant U.S. Attorney Sara Bloom and Trial Attorney Sanjay Bhambhani -- and the National Medicaid Fraud Control Units team, headed by Massachusetts Assistant Attorney General Robert Patten.

Kopchinski expressed gratitude to the government and to his wife for her support throughout the six years he pursued the case. "The past six years have been very stressful," he said. "I'm glad it's finally over."

About Phillips & Cohen LLP

Phillips & Cohen LLP is the most successful law firm representing whistleblowers in the nation. "Qui tam" lawsuits brought by Phillips & Cohen have resulted in civil and criminal recoveries totaling $5.2 billion. The firm's attorneys are regularly recognized for their successful work on whistleblower cases with inclusion on such lists as the Top 10 "Winning Attorneys" in the U.S., the "100 Most Influential Lawyers" and the National Law Journal's "Hot List" of plaintiffs' law firms. For more information, see www.phillipsandcohen.com.


'/>"/>
SOURCE Phillips & Cohen LLP
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. $89 Million Proposed Class Action Settlement Provides Consumers and Insurers With Money Back for Celebrex and Bextra Purchases and Reimbursements
2. Sheller, P.C. Law Firm Instrumental in Pfizers $2.3 Billion Settlement Today in Largest Pharmaceutical Whistleblower Case in History
3. Health Insurance Whistleblower Urges Obama Health Chiefs to Join Him at Free Urban Health Care Expedition in L.A. Stadium
4. CIGNA Whistleblower Calls for More Heath Insurance Accountability in Heath Care Reform
5. Smithsonian Worker Exposed to Asbestos Files Whistleblower Retaliation Complaint
6. Nationally Recognized Medicaid Fraud Prosecutor Tim Terry Joins Successful Whistleblower Law Practice, Specializing in "Qui Tam" Citizen Suits Under False Claims Acts
7. Law Firm Freedland Russo Spearheads Record-Setting Whistleblower Case Against Pharmaceutical Giant Eli Lilly -- Firm Expands Offices to Include L.A. Entertainment Branch
8. The Largest Pharma Fraud Whistleblower Case in U.S. History Totaling $1.4 Billion
9. Whistleblowers Complaints Lead Eli Lilly to Pay $800 Million to Settle Civil Medicaid Fraud Charges, According to Berg & Androphy
10. Pennsylvania Hospital Pays $1.9 Million to Settle Medicare Fraud Case Brought by Whistleblower
11. Walgreens Pays $35 Million, Settles Pharmacist-Whistleblower Qui Tam Drug Switching Allegations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology: